After a decade in the life sciences industry in Boston, I recently returned to Montreal to help launch Amplitude Ventures, to provide the acceleration capital needed to advance cutting-edge healthcare innovations.

I am passionate about supporting research in the life sciences and I believe that the mission of the Institut du cancer de Montréal, which is to support ICM researchers, will play an essential role in the development of the Montreal ecosystem and the advancement of cutting-edge therapies responding to the critical unmet need that persists in oncology.